DARWIN AG (7V0.DE) Stock Price, Forecast & Analysis

Europe • Frankfurt Stock Exchange • FRA:7V0 • DE000A3C35W0

11.5 EUR
+0.6 (+5.5%)
Last: Jan 30, 2026, 07:00 PM

7V0.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap138.00M
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares12.00M
Float12.00M
52 Week High35.2
52 Week Low6.05
Yearly DividendN/A
Dividend Yield6.78%
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2021-11-02
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
7V0.DE short term performance overview.The bars show the price performance of 7V0.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 40 -40

7V0.DE long term performance overview.The bars show the price performance of 7V0.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of 7V0.DE is 11.5 EUR. In the past month the price increased by 50.33%. In the past year, price decreased by -58.33%.

DARWIN AG / 7V0 Daily stock chart

7V0.DE Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to 7V0.DE. When comparing the yearly performance of all stocks, 7V0.DE is a bad performer in the overall market: 70.23% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

7V0.DE Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

7V0.DE Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

7V0.DE Ownership

Ownership
Inst Owners0.1%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About 7V0.DE

Company Profile

7V0 logo image Darwin AG engages in the analysis of genetic materials and provides related research and development, as well as consulting services. The company is headquartered in Muenchen, Bayern. The company went IPO on 2021-11-02. The firm develops and sells and dietary supplements and cosmetics products. The company uses advances in Biotechnology and AI to create personalized solutions based on scientific lab analysis data. The company has fully licensed laboratories cover the whole range of genetic and metabolomic testing, ranging from lifestyle personal genomics to embryo screening during IVF to improve success rates.

Company Info

DARWIN AG

Brienner Strasse 7, c/o GCI Management Consulting GmbH

Muenchen BAYERN DE

Employees: 235

7V0 Company Website

7V0 Investor Relations

Phone: 4920500450

DARWIN AG / 7V0.DE FAQ

Can you describe the business of DARWIN AG?

Darwin AG engages in the analysis of genetic materials and provides related research and development, as well as consulting services. The company is headquartered in Muenchen, Bayern. The company went IPO on 2021-11-02. The firm develops and sells and dietary supplements and cosmetics products. The company uses advances in Biotechnology and AI to create personalized solutions based on scientific lab analysis data. The company has fully licensed laboratories cover the whole range of genetic and metabolomic testing, ranging from lifestyle personal genomics to embryo screening during IVF to improve success rates.


Can you provide the latest stock price for DARWIN AG?

The current stock price of 7V0.DE is 11.5 EUR. The price increased by 5.5% in the last trading session.


Does 7V0 stock pay dividends?

DARWIN AG (7V0.DE) has a dividend yield of 6.78%. The yearly dividend amount is currently 0.


How is the ChartMill rating for DARWIN AG?

7V0.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


What is DARWIN AG worth?

DARWIN AG (7V0.DE) has a market capitalization of 138.00M EUR. This makes 7V0.DE a Micro Cap stock.


Can you provide the ownership details for 7V0 stock?

You can find the ownership structure of DARWIN AG (7V0.DE) on the Ownership tab.